Cite
[Erythrocyte aggregation and retinal vein occlusion. Preliminary data for a randomized study on the efficacy of anti-erythrocyte aggregation (troxerutin) in retinal vein occlusion].
MLA
Glacet-Bernard, A., et al. “[Erythrocyte Aggregation and Retinal Vein Occlusion. Preliminary Data for a Randomized Study on the Efficacy of Anti-Erythrocyte Aggregation (Troxerutin) in Retinal Vein Occlusion].” Bulletin Des Societes d’ophtalmologie de France, vol. 89, no. 12, Dec. 1989, pp. 1393–96. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=2632113&authtype=sso&custid=ns315887.
APA
Glacet-Bernard, A., Coscas, G., Lelong, F., Chabanel, A., Samama, M., & Taccoen, A. (1989). [Erythrocyte aggregation and retinal vein occlusion. Preliminary data for a randomized study on the efficacy of anti-erythrocyte aggregation (troxerutin) in retinal vein occlusion]. Bulletin Des Societes d’ophtalmologie de France, 89(12), 1393–1396.
Chicago
Glacet-Bernard, A, G Coscas, F Lelong, A Chabanel, M Samama, and A Taccoen. 1989. “[Erythrocyte Aggregation and Retinal Vein Occlusion. Preliminary Data for a Randomized Study on the Efficacy of Anti-Erythrocyte Aggregation (Troxerutin) in Retinal Vein Occlusion].” Bulletin Des Societes d’ophtalmologie de France 89 (12): 1393–96. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=2632113&authtype=sso&custid=ns315887.